Volver a Agenda
OS16 What is the Quality of Real World Evidence?
Session Chair(s)
Daisaku Sato, PhD, MPharm, RPh
Councilor for Pharmaceutical Affairs
Ministry of Health, Labour and Welfare, Japan
Speaker(s)
Masao Iwagami, MD, PhD
University of Tsukuba, Japan
Assistant Professor, Faculty of Medicine
Hisashi Urushihara, DrPH
Keio University, Japan
Professor, Faculty of Pharmacy, Department of Pharmacy
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Catherine Cohet, PhD
European Medicines Agency, Netherlands
Senior Pharmacoepidemiologist, Data Analytics and Methods Task Force
¿Tiene una cuenta?